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Ex Situ Machine Perfusion of Human Donor Livers 
via the Surgically Reopened Umbilical Vein:  
A Proof of Concept
Otto B. van Leeuwen, BSc,1 Masato Fujiyoshi, MD, PhD,1 Rinse Ubbink, MSc,2 Maureen J.M. Werner, MD,1 
Isabel M.A. Brüggenwirth, BSc,1 Robert J. Porte, MD, PhD,1 and Vincent E. de Meijer, MD, PhD1
INTRODUCTION
Liver transplantation is the treatment of choice for patients 
with end-stage liver disease. However, donor organ short-
age remains a limiting factor in the wider application of 
liver transplantation. This discrepancy between organ avail-
ability and demand has led to the increased use of so-called 
“extended-criteria” donor (ECD) grafts. The use of ECD liv-
ers is associated with increased rates of ischemia-reperfusion 
injury-related complications, such as primary graft nonfunc-
tion, early allograft dysfunction, and biliary complications.1 
This has led to a large number of livers being declined for 
transplantation. Ex situ oxygenated machine perfusion is 
increasingly applied to ECD livers to reduce the risk of graft 
failure and has made the transition to clinical trials.2
Recently, He et al3 reported the first case of ischemia-free 
liver transplantation in humans. Their innovative technique 
of continuous normothermic machine perfusion (NMP) dur-
ing liver procurement, preservation, and transplantation is 
a major breakthrough, because for the first time a liver was 
successfully transplanted without any ischemia or reper-
fusion. The authors used a donor iliac vein graft that was 
anastomosed end-to-side to the donor portal vein main stem 
to enable cannulation and perfusion of the portal venous 
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Original Clinical Science—Liver
Background. Machine perfusion of donor livers is typically performed via the portal vein main stem. Instead, cannulation 
of a reopened umbilical vein could allow machine perfusion during organ procurement and subsequent implantation in the 
recipient without interruption of the portal venous circulation. We aimed to assess the feasibility of portal venous machine 
perfusion via the umbilical vein. Methods. During back table inspection of 5 human livers declined for transplantation, the 
umbilical vein was surgically reopened, dilated, and cannulated. Hypothermic and normothermic oxygenated machine perfu-
sion (NMP) were performed using the umbilical vein for portal inflow. Three livers were perfused with hypothermic machine 
perfusion, 1 full liver graft underwent NMP for 4 hours, and 1 left lateral split procedure was performed under continuous 
NMP with portal perfusion via the umbilical vein. Results. In all livers, access to the portal venous system via the umbilical 
vein was successfully achieved with good portal flows and macroscopically homogeneous perfusion. The full liver graft that 
underwent NMP via the umbilical vein for 4 hours showed good lactate clearance, normalized pH, and achieved good bile 
production with pH >7.55. During the split procedure under continuous NMP via the umbilical vein, the left lateral segment 
and extended right lobe remained equally perfused, as demonstrated by Doppler ultrasound. Conclusions. Machine 
perfusion with portal perfusion via the umbilical vein is feasible. Portal venous flows were similar to those obtained after 
cannulation of the portal vein main stem. This technique enables continuous oxygenated perfusion of liver grafts during 
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system without interrupting the blood circulation, even dur-
ing porto-portal anastomosis in the recipient.3 However, this 
additional end-to-side anastomosis may predispose to throm-
bosis, potentially leading to portal venous complications.
Our group recently postulated the use of the surgically 
reopened umbilical vein as an alternative route to the portal 
venous system to overcome the need to anastomose an iliac 
vein graft to the portal vein main stem.4 Access to the por-
tal venous system via a surgically reopened umbilical vein 
has previously been used for successful retrograde tumor 
thrombectomy of the portal vein main stem.5 Therefore, 
we hypothesized that a surgically reopened umbilical vein 
would provide good access to the portal venous system for 
machine perfusion (Figure 1A and B). We here present our 
first experiences of human liver machine perfusion with por-
tal perfusion via the umbilical vein in a preclinical setting.
MATERIALS AND METHODS
Between January and May 2018, 5 human ECD livers 
declined for transplantation in the Eurotransplant region 
were offered to our center for machine perfusion research. 
FIGURE 1. Step-by-step approach for cannulation of the umbilical vein for ex situ machine perfusion. A, Schematic drawing of human 
portal venous anatomy with usual machine perfusion via the PV main stem. B, Schematic drawing of machine perfusion through the UV 
with alternative flow pattern. C, The UL of a human donor liver before dissection of the UV. D, Introduction of the FBC to pneumatically 
dilate the obliterated UV. E, Adequately dilated insertion of the UV into the left intrahepatic PV branch (denoted by the *). F, Connection 
between UV and PV main stem ensured (demonstrated by a probe). G, Cannulation of the UV with a 24F cannula. H, Normothermic 
machine perfusion via the UV and the SA. The proximal stump of the PV main stem was closed with a nontraumatic vascular clamp. 
FBC, Fogarty balloon catheter; PV, portal vein; SA, supratruncal aorta; UL, umbilical ligament; UV, umbilical vein.
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This study was approved by the medical ethical commit-
tee of the University Medical Center Groningen and the 
Dutch Transplant Society, the competent authority for 
organ donation in the Netherlands. Donor relatives pro-
vided consent for research before the donation procedure. 
For all livers, donation after circulatory death combined 
with donor age exceeding 60 years was the reason for graft 
discard. All organs were procured using a superrapid pro-
curement technique described previously.6
Organ Inspection and Preparation for Machine 
Perfusion
All livers were prepared for dual machine perfusion using 
the umbilical vein for portal perfusion and the supratrun-
cal aorta for arterial perfusion. Opening of the umbilical 
vein was performed by careful exploration of the round 
ligament of the liver (Figure 1C). As soon as the umbilical 
vein was identified and dissected, a Fogarty balloon catheter 
(8F; Edwards Life Sciences, Nyon, Switzerland) was intro-
duced to dilate the obliterated vessel (Figure 1D) to allow 
adequate opening of the entrance into the left intrahepatic 
portal vein branch (Figure  1E). In all 5 livers, a connec-
tion between the portal vein and umbilical vein could be 
obtained easily (Figure  1F). Hereafter, the portal cannula 
from the Liver Assist device (Organ Assist, Groningen, the 
Netherlands) was inserted into the umbilical vein with its 
tip close to the lumen of the left portal vein branch and was 
secured (Figure 1G). The proximal stump of the portal vein 
main stem was closed with a nontraumatic vascular clamp 
(Figure 1H). The first 3 livers were perfused hypothermi-
cally (10°C to 12°C) with University of Wisconsin Machine 
Perfusion solution (Bridge to Life, London, UK). Livers 4 
and 5 were perfused normothermically (37°C) with our clin-
ically used NMP solution containing a hemoglobin-based 
oxygen carrier.6 The hypothermic and oxygenated NMP 
procedures were performed using the Liver Assist, a pres-
sure-controlled perfusion device, as described previously.6,7
RESULTS
Hypothermic Machine Perfusion via the Umbilical 
Vein
In the first liver, a smaller cannula (12F) than usual (24F) 
was introduced in the umbilical vein. However, due to the 
increased resistance of the smaller cannula, umbilical vein 
flows were lower (80 to 100 mL/min at a preset pressure of 
5 mm Hg) than previously described during hypothermic 
machine perfusion (ie, 200 to 300 mL/min at 5 mm Hg).5 
In livers 2 and 3, the umbilical vein was cannulated with 
the usual cannula for portal vein cannulation (24F). In 
these cases, umbilical vein flow rates were similar to val-
ues obtained during normal hypothermic perfusion via the 
portal vein main stem. (ie, >200 mL/min at a pressure of 
5 mm Hg).6 Pulsatile arterial flows were comparable (75 
to 100 mL/min at a preset pressure of 25 mm Hg) to flows 
as described previously during dual hypothermic machine 
perfusion (ie, 50 to 100 mL/min at 25 mm Hg).6
Normothermic Machine Perfusion via the  
Umbilical Vein
The fourth liver was prepared for NMP through the 
umbilical vein and supratruncal aorta (Figure 2A). During 
NMP, this full liver graft cleared lactate (Figure 2B) and 
the perfusate pH reached normal values within 2 hours 
(Figure 2C). Doppler ultrasound analysis confirmed accu-
rate position of the tip of the perfusion catheter just before 
the lumen of the left portal vein branch (Figure 2D), dem-
onstrated adequate blood flow in both the left and the 
right portal venous branches (Figure 2E), as well as in all 
the hepatic veins (Figure 2F). To analyze the bile produc-
tion from the left and right liver lobe separately, both the 
left and right hepatic bile duct were cannulated and bile 
was collected from each liver lobe. The amount of bile pro-
duced was >10 mL. After 1 hour of NMP, the pH of the 
bile from both liver lobes was >7.55, and after 2 hours of 
NMP >7.65.
Experimental Ex Situ Left Lateral Segment Split 
Procedure
The fifth liver was prepared for NMP through the 
umbilical vein and supratruncal aorta to assess the feasi-
bility of a left lateral segment (LLS) split procedure under 
continuous NMP with subsequent continued machine 
perfusion of the LLS graft. The portal vein cannula (24F) 
was introduced in the umbilical vein and the arterial can-
nula in the supratruncal aorta after which NMP was 
initiated (Figure 3A). The organ was perfused at 37°C dur-
ing transection of the liver parenchyma using the CUSA 
device (Excel+; Integra LifeSciences, Tullamore, Ireland), 
followed by sharp division of the hilar plate (Figure  3B 
and C). Finally, under continuous oxygenated NMP, the 
right hepatic artery and right portal vein were divided 
and the left hepatic vein was dissected from the inferior 
vena cava. The extended right lobe was removed from 
the reservoir, while the LLS remained under continuous 
NMP (Figure 3D). The extended right lobe was immedi-
ately flushed and preserved in a bowl with University of 
Wisconsin solution and sterile ice. In the hour following 
the splitting procedure, the LLS graft cleared lactate and 
the pH of the perfusion fluid maintained within normal 
values (between 7.35 and 7.45). The umbilical venous and 
pulsatile arterial flows of the LLS remained >400 mL/min 
and 150 to 200 mL/min, respectively.
Proposed Ex Situ Split Procedure Using Continuous 
Oxygenated Hypothermic Machine Perfusion
The abovementioned concept could also be applied by 
using single (portal venous only) or dual (portal venous 
and arterial) hypothermic machine perfusion to allow con-
tinuous oxygenated LLS and extended right lobe split, or 
even full-left and full-right lobe split procedure. To do so, 
portal vein main stem and umbilical vein should both be 
cannulated with a portal vein cannula (24F). For dual per-
fusion, the arterial cannula should be introduced in the 
supratruncal aorta. For the parenchymal transection phase, 
hypothermic oxygenated machine perfusion can be initi-
ated via the cannula in the portal vein main stem, while the 
cannula in the umbilical vein should be clamped to prevent 
backflow (Figure 3E). After division of the hilar plate, the 
left portal vein can be divided and clamped. Portal venous 
perfusion via the umbilical vein can be initiated to perfuse 
the LLS or full-left lobe, while continuous perfusion of the 
extended right lobe or full-right lobe is maintained via the 
portal vein main stem (Figure 3F). After division of the left 
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hepatic artery, perfusion via the supratruncal aorta allows 
dual hypothermic oxygenated machine perfusion of the 
extended right lobe or full-right lobe, whereas the LLS or 
full-left lobe can be perfused via the umbilical vein only.
DISCUSSION
In this proof of concept study, we show for the first time 
that machine perfusion of human donor livers via the sur-
gically reopened umbilical vein instead of the portal vein 
main stem is technically feasible. This modification may 
simplify the previously described technique of ischemia-
free liver transplantation as it may allow procurement, 
preservation, as well as implantation with a standard end-
to-end porto-portal anastomosis in the recipient under 
continuous oxygenated portal venous machine perfusion 
via the umbilical vein, without the need to anastomose an 
iliac vein graft to the portal vein main stem. We also dem-
onstrate the technical feasibility of an LLS split procedure 
under continuous NMP via the surgically reopened umbili-
cal vein as well as the supratruncal aorta.
The first 3 livers were perfused hypothermically, during 
which it is currently not possible to perform viability testing. 
We have assessed the flow rates through the umbilical vein 
and compared this with the usual portal vein flows observed 
in our clinical hypothermic machine perfusions in humans.6 
We noticed that when using a standard 24F cannula for 
umbilical vein perfusion, flows were comparable to typical 
hypothermic perfusion via the portal vein main stem (200 
to 300 mL/min). Meticulous care should be taken to avoid 
twisting of the umbilical vein cannula because we observed 
that this immediately impaired portal venous flow.
The fourth liver perfusion experiment demonstrated 
that our clinically used viability criteria for donor livers 
FIGURE 2. Ex situ evaluation of the liver that underwent NMP via the umbilical vein. A, Macroscopic appearance of the liver during NMP 
via the umbilical vein. B, Lactate clearance of the full liver graft during NMP. C, Normalization of perfusate pH of the full liver graft during NMP. 
No sodium bicarbonate was administered. D, Ultrasound image with Doppler acknowledging the position of the 24F perfusion cannula 
(denoted by the *) in the UV. E, Ultrasound image with Doppler demonstrating the patency of peripheral PV branches in the right liver lobe. 
F, Ultrasound image with Doppler visualizing adequate venous outflow from the RHV. LPV, left portal vein; NMP, normothermic machine 
perfusion; PV, portal vein; RHV, right hepatic vein; SA, supratruncal aorta; S7 PV, segment 7 portal vein branch; UV, umbilical vein.
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during NMP2 (after 150 min of NMP: perfusate lactate 
<1.7 mmol/L, perfusate pH between 7.35 and 7.45, bile pH 
>7.45; Dutch Trial Register No. NTR5972) were reached 
by using portal venous perfusion via the umbilical vein.
In the fifth liver, we have performed an LLS split pro-
cedure under continuous NMP using portal venous per-
fusion via the surgically reopened umbilical vein. After 
completion of the split procedure, NMP of the LLS was 
continued. In the following hour, lactate was cleared and 
the pH remained within normal values. We propose that 
by introducing a cannula in the portal vein main stem as 
well as a cannula in the surgically reopened umbilical vein, 
machine perfusion of the LLS or full-left lobe as well as the 
extended right or full-right lobe can be maintained even 
after complete separation of the 2 liver parts.
We envision that splitting under continuous oxygen-
ated hypothermic machine perfusion could be beneficial, 
for example, for logistical reasons to allow sequential 
liver transplantation in the same center (conceptualized in 
Figure 3E and F). Also, hypothermic oxygenated machine 
perfusion is less prone to technical failure and is associated 
with lower flow rates when using a pressure-controlled 
machine perfusion device. We have, however, not experi-
enced trouble with flow obstruction during the NMP split 
procedure. When using continuous oxygenated hypother-
mic machine perfusion, the transfer from one machine to 
another or to static cold storage before implantation can 
be performed without additional warm ischemic injury. At 
normothermic temperatures, we do not consider it benefi-
cial to perfuse both the extended right or full-right lobe and 
FIGURE 3. Step-by-step approach to perform an ex situ continuous oxygenated liver split procedure using the umbilical vein. A, 
Experimental setting for the splitting of liver 5. The PV was clamped and the whole liver graft was perfused normothermically via the UV. 
B, The LLS was perfused with NMP via the UV and SA after the splitting. The ERL was removed from the perfusion device and preserved 
on ice. The LLS was perfused with NMP via the UV and SA after the splitting. The ERL was removed from the perfusion device and 
preserved on ice. C, LLS procedure during continuous NMP. D, NMP of LLS after splitting under NMP via the UV and SA. E, Conceptual 
clinical ex situ splitting procedure: until PV dissection, continuous oxygenated machine perfusion via the PV main stem is performed. 
The UV is cannulated but clamped to prevent blackflow. F, Conceptual ex situ split procedure: after PV dissection, hypothermic machine 
perfusion via both the PV main stem and UV allows continuous oxygenation of both partial liver grafts during and after splitting. ERL, 
extended right lobe; LHV, left hepatic vein; LLS, left lateral segment; NMP, normothermic machine perfusion; PV, portal vein; SA, 
supratruncal aorta; UV, umbilical vein.
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the LLS or full-left lobe simultaneously. For NMP, arterial 
perfusion is required and arterial cannulation of either the 
left or the right hepatic artery may risk additional injury 
to the vascular endothelium. Therefore, we propose that 
continuous hypothermic oxygenated machine perfusion 
during splitting will be most beneficial in clinical practice.
In this proof of concept study, we have demonstrated 
for the first time that machine perfusion through the surgi-
cally reopened umbilical vein in discarded human livers 
is technically feasible, thereby achieving adequate portal 
venous flows. Future studies should investigate the addi-
tional clinical utility of machine perfusion via the umbili-
cal vein, which should include histopathological analysis 
of the parenchyma and biliary tree.
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